mTOR Signal Transduction Pathways Contribute to TN-C FNIII A1 Overexpression by Mechanical Stress in Osteosarcoma Cells

다국어 초록 (Multilingual Abstract)

Osteosarcoma is the most common primary malignant bone tumor with a very poor prognosis. Treating osteosarcoma remains a challenge due to its high transitivity. Tenascin-C, with large molecular weight variants including different combinations of its alternative spliced FNIII repeats, is specifically over expressed in tumor tissues. This study examined the expression of Tenascin-C FNIIIA1 in osteosarcoma tissues, and estimated the effect of mechanical stimulation on A1 expression in MG-63 cells. Through immunohistochemical analysis, we found that the A1 protein was expressed at a higher level in osteosar-coma tissues than in adjacent normal tissues. By cell migration assay, we observed that there was a significant correlation between A1 expression and MG-63 cell migra-tion. The relation is that Tenascin-C FNIIIA1 can promote MG-63 cell migration. According to our further study into the effect of mechanical stimulation on A1 expression in MG-63 cells, the mRNA and protein levels of A1 were significantly up-regulated under mechanical stress with the mTOR molecule proving indispensable. Meanwhile, 4E-BP1 and S6K1 (downstream molecule of mTOR) are necessary for A1 normal expression in MG-63 cells whether or not mechanical stress has been encountered. We found that Tenascin-C FNIIIA1 is over-expressed in osteosar-coma tissues and can promote MG-63 cell migration. Furthermore, mechanical stress can facilitate MG-63 cell migration though facilitating A1 overexpression with the necessary molecules (mTOR, 4E-BP1 and S6K1). In con-clusion, high expression of A1 may promote the meta-stasis of osteosarcoma by facilitating MG-63 cell migration. Tenascin-C FNIIIA1 could be used as an indicator in metastatic osteosarcoma patients.

참고문헌 (Reference)

1 Zhang, Y., "mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors" 11 : 594-603, 2012

2 Oh, W. J., "mTOR complex 2 signaling and functions" 10 : 2305-2316, 2011

3 Midwood, K. S., "The role of tenascin-C in tissue injury and tumorigenesis" 3 : 287-310, 2009

4 Tucker, R. P., "The regulation of tenascin expression by tissue microenvironments" 1793 : 888-892, 2009

5 Murphy-Ullrich, J. E., "The de-adhesive activity of matricellular proteins : is intermediate cell adhesion an adaptive state?" 107 : 785-790, 2001

6 Tamaoki, M., "Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury" 167 : 71-80, 2005

7 Ramos, D. M., "Tenascin-C matrix assembly in oral squamous cell carcinoma" 75 : 680-687, 1998

8 Alves, T. R., "Tenascin-C in the extracellular matrix promotes the selection of highly proliferative and tubulogenesisdefective endothelial cells" 317 : 2073-2085, 2011

9 Jahkola, T., "Tenascin-C expression in invasion border of early breast cancer : a predictor of local and distant recurrence" 78 : 1507-, 1998

10 Wachtel, M., "Targets for cancer therapy in childhood sarcomas" 36 : 318-327, 2010

11 Wullschleger, S., "TOR signaling in growth and metabolism" 124 : 471-484, 2006

12 Jiang, L., "Synergistic effects of cyclic strain and Th1-like cytokines on tenascin-C production by rheumatic aortic valve interstitial cells" 155 : 216-223, 2008

13 Rhee, S. H., "Role of integrin-linked kinase in osteosarcoma progression" 31 : 1668-1675, 2013

14 Si, Y., "Plateletderived growth factor induced alpha-smooth muscle actin expression by human retinal pigment epithelium cell" 29 : 310-318, 2013

15 Tucker, R., "Phylogenetic analysis of the tenascin gene family : evidence of origin early in the chordate lineage" 6 : 60-, 2006

16 Yuan, T., "PI3K pathway alterations in cancer : variations on a theme" 27 : 5497-5510, 2008

17 Li, R., "PDGFC and-D induced proliferation/migration of human RPE is abolished by inflammatory cytokines" 48 : 5722-5732, 2007

18 Bielack, S., "Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up" 20 : iv137-iv139, 2009

19 Gill, J., "New targets and approaches in osteosarcoma" 137 : 89-99, 2012

20 Ma, X. M., "Molecular mechanisms of mTORmediated translational control" 10 : 307-318, 2009

21 Wang, Y., "Mechanical strain and growth factors regulate expression of tenascin-C by OS cells additively" 20 : 509-516, 2006

22 Ehrlich, P., "Mechanical strain and bone cell function : a review" 13 : 688-700, 2002

23 Feng, X., "Lipopolysaccharide up-regulates the expression of Fcα/μ receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages" 208 : 396-405, 2010

24 Andrianarivo, A. G., "Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells" 153 : 256-265, 1992

25 Wang, Y., "Generation and identification of monoclonal antibodies against FNIII domain D of human tenascin-C" 29 : 13-16, 2010

26 Sage, E., "Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin" 266 : 14831-14834, 1991

27 Leins, A., "Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma" 98 : 2430-2439, 2003

28 Hirata, E., "Endogenous tenascin-C enhances glioblastoma invasion with reactive change of surrounding brain tissue" 100 : 1451-1459, 2009

29 Pazzaglia, L., "Differential gene expression in classic giant cell tumours of bone : tenascin C as biological risk factor for local relapses and metastases" 57 : 59-72, 2010

30 Wu, G., "Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma : Improvement in the sensitivity or specificity?" 41 : 975-983, 2013

31 Chung, C. Y., "Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J" 126 : 539-548, 1994

32 Lelievre, S., "Cell nucleus in context" 10 : 30-37, 2000

33 Shimoyama, T., "CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration" 30 : 675-682, 2010

34 Zilan Lv, "Bone Morphogenetic Protein 9 Overexpression Reduces Osteosarcoma Cell Migration and Invasion" 한국분자세포생물학회 36 (36): 119-126, 2013

35 Midwood, K. S., "Advances in tenascin-C biology" 68 : 3175-3199, 2011

36 Skelly, D. T., "A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1B, TNF-α and IL-6 challenges in C57BL/6 mice" 8 : e69123-, 2013

37 Osborne, T., "A review of the association between osteosarcoma metastasis and protein translation" 146 : 132-142, 2012

38 Saito, Y., "A peptide derived from tenascin-C induces β1 integrin activation through syndecan-4" 282 : 34929-34937, 2007